A DRD2 polymorphism predicts PANSS score variability in schizophrenia patients treated with antipsychotics.
Voisey
Joanne
J
Swagell
Christopher D
CD
Hughes
Ian P
IP
Barnes
Mark
M
Burton
Simon C
SC
van Daal
Angela
A
Morris
C Phillip
CP
Lawford
Bruce R
BR
Young
Ross McD
RM
D000328:Adult; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008137:Longitudinal Studies; D008297:Male; D008875:Middle Aged; D011110:Polymorphism, Genetic / Q000235:genetics*; D011237:Predictive Value of Tests; D011569:Psychiatric Status Rating Scales; D017448:Receptors, Dopamine D2 / Q000235:genetics*; D012559:Schizophrenia / Q000188:drug therapy* / Q000235:genetics*; D055815:Young Adult
D014150:Antipsychotic Agents; D017448:Receptors, Dopamine D2